Search Icon
SideMenu

Resources

Find up-to-date information on generics and biosimilars

  • Reset
  • Press Releases

AAM Comments on Section 232 Investigation on Pharmaceuticals
  • Press Releases

AAM Commends Senate Q1/Q2 Bill Introduction
  • Press Releases

AAM Congratulates Dr. Oz on Confirmation as Administrator of the Centers for Medicare & Medicaid Services
  • Press Releases

AAM Comments on staff layoffs at FDA
  • Press Releases

AAM Congratulates FDA Commissioner Makary
  • Press Releases

AAM Commends Q1/Q2 House Bill Reintroduction
  • Press Releases

Association for Accessible Medicines on Confirmation of Robert F. Kennedy Jr. as Secretary of Health and Human Services
  • Blog

The IRA Hurts Generic and Biosimilar Medication Competition
  • Blog

Access! 2025 Recap: A Call to Action for the Future of Generics and Biosimilars
  • Blog

Your All ACCESS! Pass
  • Press Releases

Association for Accessible Medicines 2025 Advocacy Priorities
  • Press Releases

Association for Accessible Medicines Comments on New Tariffs

Generics

are a proven prescription for a healthier society.

Generic and biosimilar medicines make it easier and more affordable for patients to live healthier lives.

Learn More
Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington DC 20001
JOIN

Advocacy

About Us

Events

Resources

Sign-up for Update

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Subscribe

© 2025 Association for Accessible Medicines (AAM), All Rights Reserved
Privacy Policy  |  Terms of Use  |  Contact

Stay Connected

For the latest updates, follow us on social media.

Facebook-f X-twitter Linkedin-in Youtube Instagram